• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Prevention of colitic cancer by IL-6 trans-signaling inhibitors

Research Project

Project/Area Number 19590741
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionKurume University

Principal Investigator

MITSUYAMA Keichi  Kurume University, 医学部, 准教授 (20200066)

Co-Investigator(Kenkyū-buntansha) TSURUTA Osamu  久留米大学, 医学部, 教授 (60197770)
KUWAKI Kotaro  久留米大学, 医学部, 助教 (60425171)
Project Period (FY) 2007 – 2009
Project Status Completed (Fiscal Year 2009)
Budget Amount *help
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2009: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2008: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2007: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Keywords炎症性腸疾患 / colitic cancer / IL-6 trans-signaling / STAT3 / 可溶性gp130-Fc / 可溶性gp 130-Fc / 可溶性gp130
Research Abstract

Colitic cancer is a large bowel cancer that occurs in a long-standing inflammatory bowel disease. The role of the IL-6/STAT3 pathway in the development of colitic cancer has not been fully understood. This study was conducted to investigate whether IL-6 trans-signaling contributes to the development of colitic cancer. Chronic colitis was induced by dextran sodium sulfate (DSS) to BALB/c mice. Colitic cancer was induced by additional DSS treatment to colitis-affected mice. IL-6 expression increased in the colon of colitis- and colitic cancer-affected mice, and this expression was restricted to lamina propria-macrophages. Both IL-6R and TACE expressions increased in macrophages in colitis tissue, and soluble IL6R was increased in these tissues. In contrast, IL-6R generation was reduced in the colonic epithelial cells in colitis- and colitic cancer-mice and was associated with increased expression of gp130 and phospho-STAT3. It should be noted that pre-treatment of soluble gp130Fc significantly reduced the tumorigenesis in the colon. IL-6 trans-signaling in epithelial cells, induced by macrophage-derived IL-6/soluble IL-6R, plays a crucial role in the development of colitic cancer. Soluble gp130Fc may be effective for the prevention of colitic cancer.

Report

(4 results)
  • 2009 Annual Research Report   Final Research Report ( PDF )
  • 2008 Annual Research Report
  • 2007 Annual Research Report
  • Research Products

    (20 results)

All 2010 2009 2008 2007

All Journal Article (10 results) (of which Peer Reviewed: 6 results) Presentation (10 results)

  • [Journal Article] A component of polysaccharide peptidoglycan complex on Lactobacillus induced an improvement of murine model of inflammatory bowel disease and colitis-associated cancer2010

    • Author(s)
      Matsumoto S, Hara T, Nagaoka M, Mike A, Mitsuyama K, Sako T, Yamamoto M, Kado S, Takada T.
    • Journal Title

      Immunology. (in press)

    • Related Report
      2009 Final Research Report
  • [Journal Article] Essential Roles of IL-6 Trans-Signaling in Colonic Epithelial Cells, Induced by the IL-6/Soluble-IL-6 Receptor Derived from Lamina Propria Macrophages, on the Development of Colitis-Associated Premalignant Cancer in a Murine Model.2010

    • Author(s)
      Matsumoto S, Hara T, Mitsuyama K, Yamamoto M, Tsuruta O, Sata M, Scheller J, Rose-John S, Kado S, Takada T.
    • Journal Title

      J Immunol. 184(3)

      Pages: 1543-51

    • Related Report
      2009 Final Research Report
  • [Journal Article] A component of polysaccharide peptidoglycan complex on Lactobacillus induced an improvement of murine model of inflammatory bowel disease and colitis-associated cancer2010

    • Author(s)
      Matsumoto S, Hara T, Nagaoka M, Mike A, Mitsuyama K, Sako T, Yamamoto M, Kado S, Takada T.
    • Journal Title

      Immunology. (In press)

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitis-associated premalignant cancer in a murine model2010

    • Author(s)
      Matsumoto S, Hara T, Mitsuyama K, Yamamoto M, Tsuruta O, Sata M, Scheller J, Rose-John S, Kado S, Takada T.
    • Journal Title

      J Immunol 184

      Pages: 1543-51

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Interleukin-6 trans-signaling and colonic cancer associated with inflammatory bowel disease2009

    • Author(s)
      Rose-John S, Mitsuyama K, Matsumoto S, Thaiss WM, Scheller J.
    • Journal Title

      Curr Pharm Des. 15(18)

      Pages: 2095-103

    • Related Report
      2009 Final Research Report
  • [Journal Article] Interleukin-6 trans-signaling and colonic cancer associated with inflammatory bowel disease2009

    • Author(s)
      Rose-John S, Mitsuyama K, Matsumoto S, Thaiss WM, Scheller J.
    • Journal Title

      Curr Pharm Des 15

      Pages: 2095-103

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Gut microflora : a new target for therapeutic approaches in inflammatory bowel disease2008

    • Author(s)
      Keiichi Mitsuyama, Miohio Sata
    • Journal Title

      Expert opinion on therapeutic targets 12

      Pages: 301-312

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Sub-classification of type VI pit patterns in colorectal tumors : relation to the depth of tumor invasion2008

    • Author(s)
      Takeshi Tobaru, Keiichi Mitsuyama, Osamu Tsuruta, Hiroshi Kawano, Michio Sata
    • Journal Title

      International Journal of Oncology 33

      Pages: 503-508

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Therapeutic strategies for targeting the IL-6/STAT3 cytokine signaling pathway in inflammatory bowel disease.2007

    • Author(s)
      Mitsuyama K, Matsumoto S, Masuda J, Yamasakii H, Kuwaki K, Takedatsu H, Sata M.
    • Journal Title

      Anticancer Res. 27(6A)

      Pages: 3749-56

    • Related Report
      2009 Final Research Report
  • [Journal Article] Therapeutic strategies for targeting the IL-6/STAT3 cytokine signaling pathway in inflammatory bowel disease2007

    • Author(s)
      Mitsuyama K, Matsumoto S, Masuda J, Yamasakii H, Kuwaki K, Takedatsu H, Sata M
    • Journal Title

      Anticancer Res 27

      Pages: 3749-56

    • Related Report
      2007 Annual Research Report
    • Peer Reviewed
  • [Presentation] 腸内細菌による大腸粘膜樹状細胞のTNFαconverting enzyme (TACE)の発現誘導とTCRβ/p53二重欠損マウスにおける大腸発癌の関連性2009

    • Author(s)
      Mayuko Yamamoto, Satoshi Matsumoto, Keiichi Mitsuyama, Masanobu Nanno
    • Organizer
      第39回日本免疫学会総会・学術集会
    • Place of Presentation
      大阪
    • Year and Date
      2009-12-02
    • Related Report
      2009 Final Research Report
  • [Presentation] 腸内細菌による大腸粘膜樹状細胞のTNFα converting enzyme(TACE)の発現誘導とTCRβ/p53二重欠損マウスにおける大腸発癌の関連性2009

    • Author(s)
      Mayuko Yamamoto, Satoshi Matsumoto, Keiichi Mitsuyama, Masanobu Nanno
    • Organizer
      第39回日本免疫学会総会・学術集会
    • Place of Presentation
      大阪 大阪国際会議場
    • Related Report
      2009 Annual Research Report
  • [Presentation] IL6トランスシグナリングを介した大腸発癌過程における粘膜マクロファージの重要性2008

    • Author(s)
      Satoshi Matsumoto, Mayuko Yamamoto, Keiichi Mitsuyama, Stefan Rose-John
    • Organizer
      第38回日本免疫学会総会・学術集会
    • Place of Presentation
      京都
    • Related Report
      2009 Final Research Report
  • [Presentation] Colitis-associated cancer発症過程におけるIL6トランスシグナリングの重要性と粘膜マクロファージ2008

    • Author(s)
      松本敏、光山慶一、山本真悠子
    • Organizer
      JDDW(第50回日本消化器病学会大会)
    • Place of Presentation
      東京
    • Related Report
      2009 Final Research Report
  • [Presentation] L. caseiシロタ株の抗炎症作用を利用したマウスcolitis-associated-cancer抑制効果の解析2008

    • Author(s)
      山本真悠子、光山慶一、松本敏
    • Organizer
      第94回日本消化器病学会総会
    • Place of Presentation
      福岡
    • Related Report
      2009 Final Research Report
  • [Presentation] Probiotic Lactobacillus for the experimental treatment of intestinal2007

    • Author(s)
      Keiichi Mitsuyama, Satoshi Matsumoto
    • Organizer
      International Conference on Food Factors for Health Promotion 2007
    • Place of Presentation
      Kyoto, Japan
    • Related Report
      2009 Final Research Report
  • [Presentation] Colitis-associated cancer発症におけるIL-6トランスシグナリングの関与/Roles of IL-6 transsignaling on the pathogenesis of colitis-associated cancer2007

    • Author(s)
      山本真悠子、光山慶一、松本敏
    • Organizer
      第37回日本免疫学会総会・学術集会
    • Place of Presentation
      東京
    • Related Report
      2009 Final Research Report
  • [Presentation] Colitis-associated-cancer (CAC)モデルの粘膜免疫応答の解析2007

    • Author(s)
      松本敏、光山慶一、梅崎良則
    • Organizer
      JDDW(第74回日本消化器内視鏡学会総会、第49回日本消化器病学会大会合同)
    • Place of Presentation
      神戸
    • Related Report
      2009 Final Research Report
  • [Presentation] マウスcolitis-associated-cancer (CAC)モデルの免疫応答とL. caseiシロタ株の抗炎症効果を利用したCAC抑制効果の解析2007

    • Author(s)
      松本敏、原妙子、長岡正人、光山慶一、須田一恵、島龍一郎、今岡明美、瀬戸山裕美、梅崎良則
    • Organizer
      第11回腸内細菌学会
    • Place of Presentation
      東京
    • Related Report
      2009 Final Research Report
  • [Presentation] IL-6 trans-signalingを標的としたSAMP1/Yit腸炎の治療2007

    • Author(s)
      光山慶一、松本敏、増田淳也、桑木光太郎、山崎博、佐田通夫
    • Organizer
      第93回日本消化器病学会総会
    • Place of Presentation
      青森
    • Related Report
      2009 Final Research Report

URL: 

Published: 2007-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi